Remove 2025 Remove Eating disorders Remove Personality disorders
article thumbnail

Introducing the Borderline Personality Disorder Inventory

Psychiatric Times

SHOW MORE Discover the innovative Borderline Personality Disorder Inventory (BPD-I™), a psychodynamically-informed tool for assessing BPD symptoms effectively. Наталья Добровольска/AdobeStock Borderline personality disorder (BPD) remains one of the most commonly misunderstood and challenging diagnoses in mental health.

article thumbnail

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

The second quarter of 2025 saw some huge successes and fails in the psychiatric treatment pipeline. What percentage of 2025 Q2 psychiatric pipeline news was positive vs negative? Learn more in this exclusive article.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 2025 Summer Heatwave: Implications for Patients With Psychiatric Disorders

Psychiatric Times

Related Videos Related Content Advertisement June 13th 2025 Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score John J. Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now! Goldberg, MD, and Anita H.

article thumbnail

Brief Book Reviews: July 2025

Psychiatric Times

Related Videos Related Content Advertisement June 6th 2025 Brief Book Reviews: June 2025 Edmund S. Gold, MD, MS May 5th 2025 Brief Book Reviews: May 2025 Edmund S. Higgins, MD April 8th 2025 Lorazepam and the White Lotus in our Tariff Times H. Higgins, MD March 3rd 2025 Brief Book Reviews: March 2025 Edmund S.

article thumbnail

Exploring NMDA Antagonists for MDD

Psychiatric Times

Presented at: Southern California Psychiatry Conference; July 11-12, 2025; Huntington Beach, CA. Accessed July 11, 2025. January 21, 2025. Related Videos Related Content Advertisement July 11th 2025 Are You Ready for the Southern California Psychiatry Conference? Psychiatric Times. May 19, 2022. Psychiatric Times.

article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

June 23, 2025. September 11, 2025. With MDMA on hold, what’s next for psychedelics? Psychiatric Times. link] Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!

article thumbnail

sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia

Psychiatric Times

July 8, 2025. sNDA submitted: lumateperone as adjunctive therapy for major depressive disorder. Related Videos Related Content Advertisement July 7th 2025 The Psychiatric Pipeline in Review: Quarter 2, 2025 Leah Kuntz September 27th 2021 Treating ‘Morally Objectionable’ Patients James L. News release. Psychiatric Times.